Sound View Wealth Advisors Group, LLC
Position in KRYS — Krystal Biotech, Inc.
CIK 1784777
SAVANNAH, GA
Position in KRYS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$411,762
+$22,476 QoQ
Shares Held
1,594
+0.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.8155583437892095.ToString("F0")%
Shared 0.ToString("F0")%
None 99.1844416562108.ToString("F0")%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sound View Wealth Advisors Group, LLC holds $6,368,022 across 7 Biotechnology names. KRYS ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,445 | $1,889,104 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,863 | $1,724,984 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
8,898 | $1,682,166 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,516 | $424,578 | |
| 5 | KRYS |
Krystal Biotech, Inc.
This page
|
1,594 | $411,762 | |
| 6 | ARGX |
Argenx SE
|
315 | $230,028 | |
| 7 | CALC |
CalciMedica, Inc.
|
10,000 | $5,400 |
All Filings in KRYS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $411,762 | 1,594 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $389,286 | 1,579 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $353,589 | 2,003 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $267,634 | 1,947 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $273,154 | 1,515 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $222,457 | 1,420 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $218,436 | 1,200 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||